U.S. FDA pulls authorization for GSK-Vir's COVID therapy amid rising BA.2 cases

Canada News News

U.S. FDA pulls authorization for GSK-Vir's COVID therapy amid rising BA.2 cases
Canada Latest News,Canada Headlines
  • 📰 CTVNews
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 99%

The U.S. health regulator said on Tuesday GlaxoSmithKline GSK.L and Vir Biotechnology's VIR.

The U.S. health regulator said on Tuesday GlaxoSmithKline GSK.L and Vir Biotechnology's VIR.O antibody therapy was no longer authorized as a COVID-19 treatment, with data suggesting it was unlikely to be effective against the dominant Omicron sub-variant in the country.

The highly contagious BA.2 coronavirus sub-variant is estimated to make up about three of every four COVID-19 cases in the United States, according to the latest government data. GSK spokeswoman Lyndsay Meyer said on Tuesday as COVID continues to evolve and new variants emerge, the company expects governments and health systems will continue to need a diverse arsenal of vaccine and therapeutic options, and the company will continue to work with them to ensure ongoing access to sotrovimab.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CTVNews /  🏆 1. in CA

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

U.S. FDA pulls authorization for GSK-Vir’s COVID-19 therapy amid rising Omicron sub-variant casesU.S. FDA pulls authorization for GSK-Vir’s COVID-19 therapy amid rising Omicron sub-variant casesThe U.S. health regulator pulls its authorization for GSK-Vir’s COVID-19 therapy in the U.S. The move comes as a blow as GlaxoSmithKline and Vir saw high demand for sotrovimab
Read more »

U.S. FDA pulls authorization for GSK-Vir’s COVID-19 therapy amid rising Omicron sub-variant casesU.S. FDA pulls authorization for GSK-Vir’s COVID-19 therapy amid rising Omicron sub-variant casesThe U.S. health regulator pulls its authorization for GSK-Vir’s COVID-19 therapy in the U.S. The move comes as a blow as GlaxoSmithKline and Vir saw high demand for sotrovimab
Read more »

Quebec extends mask mandate for month of April amid rise in COVID-19 hospitalizationsQuebec extends mask mandate for month of April amid rise in COVID-19 hospitalizationsThe Quebec government said the province will maintain the mask mandate for indoor public spaces until at least the end of April due to a rise in COVID-19 cases and hospitalizations
Read more »

Two provinces extend mask rules, some expand access to fourth doses of COVID vaccineTwo provinces extend mask rules, some expand access to fourth doses of COVID vaccineSeveral Canadian provinces are bolstering their defences against COVID-19 amid signs of a sixth wave.
Read more »

Whole of Shanghai enters COVID lockdown despite lower symptomatic casesWhole of Shanghai enters COVID lockdown despite lower symptomatic casesThe broader lockdown came after testing saw asymptomatic COVID\u002D19 cases surge to more than 13,000.
Read more »

Toronto's top doctor urges residents to continue wearing masks indoors amid sixth wave of pandemicToronto's top doctor urges residents to continue wearing masks indoors amid sixth wave of pandemicToronto’s top doctor is urging residents to return to wearing masks in public indoor settings amid a rise in COVID-19 transmission in the city.
Read more »



Render Time: 2025-04-13 06:56:44